Patterns of recombinant growth hormone therapy use and growth responses among children with chronic kidney disease.
Derek K NgMegan K CarrollFrederick J KaskelSusan L FurthBradley A WaradyLarry A GreenbaumPublished in: Pediatric nephrology (Berlin, Germany) (2021)
Participants with growth failure receiving rGH experienced significant growth, although this was attenuated relative to RCTs, and were more likely to have higher household income and lower GFR. A substantial number of participants, predominantly boys, without diagnosed growth failure received rGH and had the highest achieved height relative to mid-parental height. Since rGH was not associated with accelerated GFR decline, increasing rGH use in this population is warranted.